Previous Article | Next Article ![]()
Infection and Immunity, May 2000, p. 3036-3039, Vol. 68, No. 5
Laboratory of Experimental Internal Medicine,
Academic Medical Center,1 and Laboratory
of Experimental and Clinical Immunology, Central Laboratory of The
Netherlands Red Cross Blood Transfusion
Service,2 University of Amsterdam,
Amsterdam, The Netherlands, and Department of Clinical
Pharmacology, Glaxo Wellcome, Greenford, United
Kingdom3
Received 5 January 2000/Accepted 2 February 2000
Metalloproteinases have been implicated in the cleavage of a number
of cell surface immune receptors. Oral administration of the
metalloproteinase inhibitor GI5402 attenuated the release of soluble
CD27 and CD16 into the circulation after intravenous endotoxin
injection in healthy humans.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Metalloproteinase Inhibitor GI5402 Inhibits Endotoxin-Induced
Soluble CD27 and CD16 Release in Healthy Humans
*
Corresponding author. Mailing address: Laboratory of
Experimental Internal Medicine, Rm. G2-105, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Phone: 31-20-5666034. Fax: 31-20-6977192. E-mail: P.E.Dekkers{at}AMC.UVA.NL.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»